NCT02057380 2024-11-20
A Rollover Study for Subjects That Have Participated in an Astellas Sponsored Linsitinib Trial
Astellas Pharma Inc
Phase 2 Completed
Clinical Trials
4 trialsNCT02638428 2020-03-19
Genomics-Based Target Therapy for Children With Relapsed or Refractory Malignancy
Samsung Medical Center
Phase 2 Unknown
NCT00039182 2013-01-24
Erlotinib in Treating Patients With Malignant Mesothelioma of the Lung
National Cancer Institute (NCI)
Phase 2 Completed
NCT00137826 2011-12-26
Bevacizumab (Avastin) and Erlotinib (Tarceva) in Previously Treated Mesothelioma
Dana-Farber Cancer Institute
Phase 2 Completed